Medical Engineered Materials Global Market Report 2024

Medical engineered materials, often referred to as biomaterials, denote substances that are specifically crafted to meet particular or customized criteria, aiming to interact with biological systems for therapeutic or diagnostic purposes in the field of medicine. Serving as a crucial link between science, technology, and medicine, these materials are employed to integrate essential elements of materials science with a deep understanding of medical design.

The principal categories of medical engineered materials include medical plastics, medical foams, medical films, medical adhesives, and medical elastomers. Medical-grade plastic materials are formulated to produce items for medical applications. These materials find use in the manufacturing of products for in vitro diagnostics and primary packaging for pharmaceuticals, ensuring the preservation and containment of medicines to prevent contamination. The diverse applications span medical devices, medical disposables, medical wearables, and advanced wound care.

The medical engineered materials market research report is one of a series of new reports that provides medical engineered materials market statistics, including medical engineered materials industry global market size, regional shares, competitors with a medical engineered materials market share, detailed medical engineered materials market segments, market trends and opportunities, and any further data you may need to thrive in the medical engineered materials industry. This medical engineered materials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical engineered materials market size has grown rapidly in recent years. It will grow from $19.59 billion in 2023 to $22.67 billion in 2024 at a compound annual growth rate (CAGR) of 15.7%. The growth observed in the historical period can be attributed to several factors, including the aging population, regulatory compliance measures, emphasis on infection control, the development of materials for implants, and advancements in tissue engineering.

The medical engineered materials market size is expected to see rapid growth in the next few years. It will grow to $38.77 billion in 2028 at a compound annual growth rate (CAGR) of 14.4%. The anticipated growth in the forecast period can be attributed to factors such as global health preparedness, the integration of 3D printing and additive manufacturing, advancements in coatings technology, the implementation of nanomedicine, and the rise of personalized medicine. Prominent trends during this period encompass the utilization of nanotechnology, the development of biodegradable and resorbable materials, the use of bioactive and smart materials, a focus on sustainability and eco-friendly materials, and continuous advancements in medical technology.

The anticipated increase in chronic diseases is poised to propel the growth of the medical engineered materials market. Chronic diseases, characterized by lasting a year or more and requiring ongoing medical attention or limiting daily activities, are driving the demand for materials that can be engineered at the nano level. Nanoengineered components are utilized to construct miniature replicas of heart chambers, offering innovative solutions for treating heart-related issues. As indicated by the National Center for Biotechnology Information (NCBI) in January 2023, the global population with chronic diseases is projected to reach 142.66 million by 2050, a significant rise from 71.522 million in 2020. Hence, the escalating instances of chronic diseases serve as a catalyst for the growth of the medical engineered materials market.

The increasing number of surgical procedures is expected to be a driving force behind the growth of the medical engineered materials market. Surgical procedures involve medical interventions that necessitate incisions or invasive techniques to access and treat internal or external body areas. This surge in surgical procedures creates a heightened demand for materials used in surgical instruments, implantable devices, and minimally invasive procedures. The critical need for biocompatible and infection-resistant materials underscores their role in ensuring patient safety. Research and development driven by customization and regulatory standards, coupled with innovations in materials prompted by cost efficiency and technological advancements, contribute to the growth of the medical engineered materials market. For example, the Organization for Economic Co-operation and Development reported an 8.4% increase in cataract surgical procedures in the Czech Republic in October 2023, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the rising number of surgical procedures acts as a growth driver for the medical engineered materials market.

Major players in the medical engineered materials market are strategically introducing new products to enhance their competitive position. An instance of this is Celanese Corporation, a US-based specialty materials company, launching Celanex MT PBT 2406MT GF20 in May 2022. This high-performance material is tailored for medical devices and various applications, offering exceptional strength, stiffness, and noise-free sliding capabilities. It finds applicability in Class I, Class II, and Class III medical device applications, as well as in automotive, electrical, electronics, industrial machinery, and consumer goods. The tribologically modified PBT+PET grade, reinforced with 20% glass fiber, provides versatile solutions across multiple industries.

Major companies in the medical engineered materials market are investing in the development of new products to gain a competitive edge. Covestro AG, a Germany-based polymer materials company, introduced Makrolon 3638 polycarbonate in February 2023. This advanced material solution, tailored for healthcare and life sciences applications, exhibits high durability across a wide temperature range, from cryogenic to steam sterilization conditions. It features high impact strength and ductility, along with high chemical resistance, meeting medical-grade and biocompatibility standards. Suitable for skin contact applications, the material is also of food contact quality and can be sterilized using common methods in the healthcare sector.

In February 2022, Celanese Corporation, a US-based global chemical leader, completed the acquisition of DuPont's resins and Advanced Solutions business lines for $11 billion. This strategic move is expected to position Celanese as a market leader with unparalleled scale, production capabilities, and technological expertise to cater to the automotive, consumer, and industrial markets. DuPont, a US-based company operating in medical engineered materials, is part of this acquisition.

Major companies operating in the medical engineered materials market include Evonik Industries AG, Covestro AG, BASF SE, Solvay SA, Saudi Basic Industries Corporation, Trelleborg AB, Koninklijke DSM N.V, Celanese Corporation, DuPont de Nemours Inc., Ethicon Inc., Henkel AG & Co. KGaA, Huntsman Corporation, Momentive Performance Materials Inc., Nitto Denko Corporation, Recticel Ltd., De Nederlandse Staatsmijnen, Victrex PLC, Ensinger GmbH, RTP Company, Foster Corporation, Zeus Industrial Products Inc., Saint-Gobain SA, Arkema SA, Eastman Chemical Company, Lubrizol Corporation, PolyOne Corporation, Quadrant AG, Rochling Group, DSM Biomedical, Invibio Ltd., Carpenter Technology Corporation, Heraeus Medical Components GmbH, CeramTec GmbH, Morgan Advanced Materials PLC, Freudenberg Medical LLC, Synectic Engineering Inc., Medtronic PLC, Abbott Laboratories, Johnson & Johnson, Siemens Healthineers AG

Asia-Pacific was the largest region in the medical engineered materials market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this medical engineered materials market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the medical engineered materials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The medical engineered materials market consists of sales of medical plastics, medical foams, medical films, medical elastomers, and medical adhesives. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.